Reliance Global Group Completes Sale of Altruis Benefit Consulting for $8 Million in Cash Plus Up to $1 Million Earnout
Reliance Global Group, Inc. (EZRA) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Reliance Global Group Completes Sale of Altruis Benefit Consulting for $8 Million in Cash Plus Up to $1 Million Earnout Second Non-Core Agency Sale Completed in September Under the Company’s Portfolio Monetization Strategy $3.1 Million Secured Promissory Note Paid in
- Consideration
- cash
- Deal value
- $8 million
Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.
How this was made
The 30-second read
Why it matters
The sale strengthens the balance sheet and provides capital for growth, but removes a revenue‑generating unit.
Market read
A small‑cap cash transaction with limited immediate market impact but indicative of the company's strategic shift.
What to watch
Future earnout depends on Altruis performance; cash holdbacks could delay full benefit.
Background
Reliance Global Group is executing a portfolio monetization strategy, selling non‑core insurance agencies to fund its AI platform development.
Ticker impact
Reliance Global Group disclosed the completion of the Altruis Benefit Consulting sale for $8 million cash plus up to $1 million earnout.
potential modest upside as balance sheet strengthens
The transaction adds cash without diluting equity, reducing financing risk and enabling growth spending.
Market effects
Shows ongoing portfolio monetization trend among InsurTech firms.
Limited to U.S. small‑cap market; no broader regional effect.
Minimal global impact.
Counterpoint
The modest cash inflow may be outweighed by loss of revenue from the divested business.
Key entities
- companyReliance Global Group, Inc.
Nasdaq‑listed InsurTech firm (ticker EZRA) selling Altruis Benefit Consulting.
- subsidiaryAltruis Benefit Consulting
Michigan‑based health insurance agency being divested.
